XIAMEN CIYUAN BIOTECH CO., LTD

XIAMEN CIYUAN BIOTECH CO., LTD Magnetic drug nano-particles, Anti-cancer new drug, Multi-carrier, Multi-target range, Multi-target point, Postpone controlled release, Reversion of multi-drug resistance, Two cure ways by oral and nasal cavity. Our *0 new innovation drugs (such as Anti-Cancer, Anti-Aids, Anti-Dengue, Anti-Malaria, Anti-cerebral thrombus etc) were successful completion of the first time pilot plant test, now looking for investment and cooperation, technology transfer. The sample of this Anti-Cancer (Broad Spectrum), was sent to authoritative government department for testing, After inside coelom test of white rat, the test results were: *9.3% for cancer restraint rate of cervical cancer U*4, The result for toxicity test was: Maximum Tolerated Dose (TMD) is *5.2g/kg, equal **2 times of the clinical human dosage. The samples of pilot plant test were passed clinical preliminary test by more *0 patients, the preliminary verification of this clinical preliminary test: definite efficacy, higher security, and less side-effects.